Showing results (91-100 of 134) with videos related to
Sort By:
Pageof 14
Journal of Clinical Microbiology|November 1, 2002
Dissemination of new methicillin-resistant Staphylococcus aureus clones in the communityKeiko Okuma, Kozue Iwakawa, John D Turnidge, et al.Computer Methods and Programs in Biomedicine|August 24, 2024
Physically informed deep neural networks for metabolite-corrected plasma input function estimation in dynamic PET imagingMatteo Ferrante, Marianna Inglese, Ludovica Brusaferri, et al.Plos One|July 3, 2013
Facial and prosodic emotion recognition deficits associate with specific clusters of psychotic symptoms in schizophreniaHuai-Hsuan Tseng, Sue-Huei Chen, Chih-Min Liu, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 15, 2017
Generalization of endothelial modelling of TSPO PET imaging: Considerations on tracer affinitiesGaia Rizzo, Mattia Veronese, Matteo Tonietto, et al.Elife|November 29, 2017
The effect of perinatal brain injury on dopaminergic function and hippocampal volume in adult lifeSean Froudist-Walsh, Michael Ap Bloomfield, Mattia Veronese, et al.Biological Psychiatry|June 25, 2025
Why Is Clozapine Uniquely Effective in Treatment-Resistant Schizophrenia? A Review and ProposalRobin M Murray, Alice Egerton, Yueming Gao, et al.Schizophrenia Bulletin|December 14, 2011
Striatal dopamine transporter availability in drug-naive patients with schizophrenia: a case-control SPECT study with [(99m)Tc]-TRODAT-1 and a meta-analysisKao Chin Chen, Yen Kuang Yang, Oliver Howes, et al.Translational Psychiatry|November 11, 2021
Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic functionPaul Allen, Emily J Hird, Natasza Orlov, et al.Human Brain Mapping|June 12, 2025
Single-Subject Network Analysis of FDOPA PET in Parkinson's Disease and Psychosis SpectrumMario Severino, Julia J Schubert, Giovanna Nordio, et al.JAMA Psychiatry|July 4, 2019
In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode PsychosisFaith Borgan, Heikki Laurikainen, Mattia Veronese, et al.Pageof 14